Literature DB >> 22689409

Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations.

Morris Sherman, Jordi Bruix, Michael Porayko, Tram Tran.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22689409     DOI： 10.1002/hep.25869

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  51 in total

1.  Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience.

Authors:  Mauro Borzio; Elena Dionigi; Angelo Rossini; Anna Toldi; Giampiero Francica; Fabio Fornari; Andrea Salmi; Fabio Farinati; Susanna Vicari; Massimo Marignani; Fulvia Terracciano; Barbara Ginanni; Rodolfo Sacco
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Response to Braillon.

Authors:  Te-Sheng Chang; Yu-Chih Wu; Ying-Huang Tsai; Yen-Hua Huang
Journal:  Am J Gastroenterol       Date:  2015-11       Impact factor: 10.864

3.  A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma.

Authors:  Jinping Liu; Wei Tang; Anuradha Budhu; Marshonna Forgues; Maria O Hernandez; Julián Candia; Yujin Kim; Elise D Bowman; Stefan Ambs; Yongmei Zhao; Bao Tran; Xiaolin Wu; Christopher Koh; Pallavi Surana; T Jake Liang; Maria Guarnera; Dean Mann; Manoj Rajaure; Tim F Greten; Zhanwei Wang; Herbert Yu; Xin Wei Wang
Journal:  Cell       Date:  2020-06-10       Impact factor: 41.582

4.  Is the American Association for the Study of Liver Diseases recommendation for hepatocellular carcinoma screening a cul-de-sac?

Authors:  Alain Braillon
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

5.  Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.

Authors:  Monica L Schmidt; A Sidney Barritt; Eric S Orman; Paul H Hayashi
Journal:  Gastroenterology       Date:  2015-01-23       Impact factor: 22.682

Review 6.  Surveillance of the Patients with High Risk of Hepatocellular Cancer.

Authors:  Necati Örmeci
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 7.  [Overview: liver tumors].

Authors:  Ivo Graziadei
Journal:  Wien Med Wochenschr       Date:  2013-01-30

8.  DKK1 as a serum biomarker for hepatocellular carcinoma.

Authors:  Peter A Prieto; Charles H Cha
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

9.  A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.

Authors:  Hashem B El-Serag; Fasiha Kanwal; Jessica A Davila; Jennifer Kramer; Peter Richardson
Journal:  Gastroenterology       Date:  2014-01-23       Impact factor: 22.682

10.  Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.

Authors:  Ehud Zigmond; Ami Ben Ya'acov; Hyunbeom Lee; Yoav Lichtenstein; Zvi Shalev; Yoav Smith; Lidya Zolotarov; Ehud Ziv; Rony Kalman; Hoang V Le; Hejun Lu; Richard B Silverman; Yaron Ilan
Journal:  ACS Med Chem Lett       Date:  2015-05-29       Impact factor: 4.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.